Cargando…

One third of hospital costs for atherothrombotic disease are attributable to readmissions: a linked data analysis

BACKGROUND: Cardiovascular disease is the most frequent cause of death in Australia, with an associated cost burden of 11% of Australian annual health expenditure of which 40% is for hospital admissions. We investigated health outcomes and the components of hospital expenditure in the two years afte...

Descripción completa

Detalles Bibliográficos
Autores principales: Atkins, Emily R, Geelhoed, Elizabeth A, Knuiman, Matthew, Briffa, Tom G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4251605/
https://www.ncbi.nlm.nih.gov/pubmed/25102911
http://dx.doi.org/10.1186/1472-6963-14-338
_version_ 1782347073388019712
author Atkins, Emily R
Geelhoed, Elizabeth A
Knuiman, Matthew
Briffa, Tom G
author_facet Atkins, Emily R
Geelhoed, Elizabeth A
Knuiman, Matthew
Briffa, Tom G
author_sort Atkins, Emily R
collection PubMed
description BACKGROUND: Cardiovascular disease is the most frequent cause of death in Australia, with an associated cost burden of 11% of Australian annual health expenditure of which 40% is for hospital admissions. We investigated health outcomes and the components of hospital expenditure in the two years after an atherothrombotic disease admission to a tertiary hospital in an Australian setting. METHODS: Using data linkage we analysed two years of hospitalisation data and death records of all men and women aged 35–84 years with an admission to a Western Australian tertiary hospital for atherothrombotic disease in 2007. Costs were identified by matching the Australian refined diagnostic related group on the admission records to the published schedules of public and private hospital costs for the period of interest, and converted to 2013 Australian dollars. RESULTS: Of 6172 patients studied (74% coronary, 20% cerebrovascular, 6% peripheral), 783 (13%) died during follow-up and 174 of these were in hospital case-fatalities at index. Thirty-two percent of patients (n = 1965) accounted for 3172 readmissions to hospital with one in three having multiple hospitalisations. The hazard ratio of atherothrombotic disease readmission was 1.45 (95% CI 1.27, 1.66) in those with more than one vascular territory affected compared to those with only one territory affected after controlling for age, sex, comorbidity, admission type, procedures, and episode length of stay. The total index plus 2-year admission cost for atherothrombotic disease was calculated at $101 million; $71 million for index, and $30 million for readmissions. CONCLUSIONS: Among patients hospitalised with atherothrombotic disease, the cost of related rehospitalisations within 24 months is almost a third of the total. Much of the readmission costs fell within the first year. Whether readmissions and cost associated with atherothrombotic disease can be lowered through secondary prevention measures requires further investigation.
format Online
Article
Text
id pubmed-4251605
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-42516052014-12-03 One third of hospital costs for atherothrombotic disease are attributable to readmissions: a linked data analysis Atkins, Emily R Geelhoed, Elizabeth A Knuiman, Matthew Briffa, Tom G BMC Health Serv Res Research Article BACKGROUND: Cardiovascular disease is the most frequent cause of death in Australia, with an associated cost burden of 11% of Australian annual health expenditure of which 40% is for hospital admissions. We investigated health outcomes and the components of hospital expenditure in the two years after an atherothrombotic disease admission to a tertiary hospital in an Australian setting. METHODS: Using data linkage we analysed two years of hospitalisation data and death records of all men and women aged 35–84 years with an admission to a Western Australian tertiary hospital for atherothrombotic disease in 2007. Costs were identified by matching the Australian refined diagnostic related group on the admission records to the published schedules of public and private hospital costs for the period of interest, and converted to 2013 Australian dollars. RESULTS: Of 6172 patients studied (74% coronary, 20% cerebrovascular, 6% peripheral), 783 (13%) died during follow-up and 174 of these were in hospital case-fatalities at index. Thirty-two percent of patients (n = 1965) accounted for 3172 readmissions to hospital with one in three having multiple hospitalisations. The hazard ratio of atherothrombotic disease readmission was 1.45 (95% CI 1.27, 1.66) in those with more than one vascular territory affected compared to those with only one territory affected after controlling for age, sex, comorbidity, admission type, procedures, and episode length of stay. The total index plus 2-year admission cost for atherothrombotic disease was calculated at $101 million; $71 million for index, and $30 million for readmissions. CONCLUSIONS: Among patients hospitalised with atherothrombotic disease, the cost of related rehospitalisations within 24 months is almost a third of the total. Much of the readmission costs fell within the first year. Whether readmissions and cost associated with atherothrombotic disease can be lowered through secondary prevention measures requires further investigation. BioMed Central 2014-08-08 /pmc/articles/PMC4251605/ /pubmed/25102911 http://dx.doi.org/10.1186/1472-6963-14-338 Text en © Atkins et al.; licensee BioMed Central Ltd. 2014 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Atkins, Emily R
Geelhoed, Elizabeth A
Knuiman, Matthew
Briffa, Tom G
One third of hospital costs for atherothrombotic disease are attributable to readmissions: a linked data analysis
title One third of hospital costs for atherothrombotic disease are attributable to readmissions: a linked data analysis
title_full One third of hospital costs for atherothrombotic disease are attributable to readmissions: a linked data analysis
title_fullStr One third of hospital costs for atherothrombotic disease are attributable to readmissions: a linked data analysis
title_full_unstemmed One third of hospital costs for atherothrombotic disease are attributable to readmissions: a linked data analysis
title_short One third of hospital costs for atherothrombotic disease are attributable to readmissions: a linked data analysis
title_sort one third of hospital costs for atherothrombotic disease are attributable to readmissions: a linked data analysis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4251605/
https://www.ncbi.nlm.nih.gov/pubmed/25102911
http://dx.doi.org/10.1186/1472-6963-14-338
work_keys_str_mv AT atkinsemilyr onethirdofhospitalcostsforatherothromboticdiseaseareattributabletoreadmissionsalinkeddataanalysis
AT geelhoedelizabetha onethirdofhospitalcostsforatherothromboticdiseaseareattributabletoreadmissionsalinkeddataanalysis
AT knuimanmatthew onethirdofhospitalcostsforatherothromboticdiseaseareattributabletoreadmissionsalinkeddataanalysis
AT briffatomg onethirdofhospitalcostsforatherothromboticdiseaseareattributabletoreadmissionsalinkeddataanalysis